by Suman Gupta
-
Capacity expansion has been implemented across multiple facilities in Hyderabad and Bangalore, to reach ~ 700 million doses / year, one of the largest production capacities for Inactivated viral vaccines worldwide,
-
IMDG agonist molecule synthesis and manufacturing has been successfully implemented in India eliminating dependency on imports,
-
Raw materials, packing materials and single use consumables for manufacturing have been secured to meet our capacity requirements,